Company / Current Assets
Tvardi Therapeutics, Inc. Current Assets History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$43.8M
FY2024
5-year range
$43.8M / $195.1M
FY2020-FY2024
Trend
-62.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has declined for 4 consecutive years, from $195M in FY2020 to $44M in FY2024.
Based on SEC 10-K filings.
$44M in FY2024 with a 5-year CAGR of -23.4%.
Declined from $169M to $44M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -36.8%
- 5-Year CAGR
- -23.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- Tvardi Therapeutics, Inc.'s current assets has declined for 4 consecutive years.
- 5-year CAGR of -23.4%, indicating a declining trend.
- In FY2024, current assets decreased 62.3% year-over-year.
- Peak current assets was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -6.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $43.8M | -62.3% |
| FY2023 | $116.2M | -31.2% |
| FY2022 | $168.9M | -2.5% |
| FY2021 | $173.3M | -11.2% |
| FY2020 | $195.1M | +17.8% |
| FY2019 | $165.7M | -1.5% |
| FY2018 | $168.1M | +76.9% |
| FY2017 | $95.1M | +54.7% |
| FY2016 | $61.4M | -43.6% |
| FY2015 | $108.9M | +105.0% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026